MyFinsight
Home
Blog
About
Comprehensive income (loss)
-$8,908K
(-3706.48%↓ Y/Y)
Net income (loss)
-$8,908K
(-3706.48%↓ Y/Y)
Auryxia
$25,463K
Vafseo
$21,302K
Japan Tobacco
Incorporation And Torii...
$1,424K
MEDICEArzneimittel Putter Gmb HCo KG
$527K
Tanabe Pharma
Corporation
$412K
Income (loss) before
income taxes
-$8,838K
(-3678.14%↓ Y/Y)
Income tax expense
$70K
Change in fair value of
warrant liability
-$566K
(-108.11%↓ Y/Y)
Product
$46,765K
(-22.65%↓ Y/Y)
License Collaboration
And Other Revenue
$2,363K
(17.50%↑ Y/Y)
Income (gain) from
operations
-$6,326K
(-144.90%↓ Y/Y)
Interest expense
-$3,071K
(55.06%↑ Y/Y)
Total revenues
$49,128K
(-21.36%↓ Y/Y)
Other income
(expense)
-$7K
(75.00%↑ Y/Y)
Total operating
expenses
$45,030K
(17.07%↑ Y/Y)
Total cost of goods
sold
$10,424K
(5.09%↑ Y/Y)
Selling, general and
administrative
$28,171K
(6.09%↑ Y/Y)
Research and development
$14,059K
(27.66%↑ Y/Y)
Restructuring
$1,945K
License
$855K
(-4.58%↓ Y/Y)
Cost of product and
other revenue
$10,424K
(5.09%↑ Y/Y)
Back
Back
Income Statement
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)
source: myfinsight.com